TrialHypertension research : official journal of the Japanese Society of Hypertension2024

Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial.

Atsushi Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.